ストックスクリーナーアプリを入手
25.13
0.36%
-0.09
アフターアワーズ：
25.63
0.50
+1.99%
前日終値:
$25.22
開ける：
$25.32
24時間の取引高:
174.63K
Relative Volume:
0.93
時価総額：
$1.11B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+10.36%
1か月 パフォーマンス:
+31.57%
6か月 パフォーマンス:
+70.26%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$24.48
$25.88
1週間の範囲:
$20.95
$25.88
52週間の値動き範囲:
$7.255
$25.88
Sionna Therapeutics Inc Stock (SION) Company Profile
名前
Sionna Therapeutics Inc
セクター
電話
617-819-2020
住所
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
25.13 | 1.11B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-04 | 開始されました | Guggenheim | Buy |
| 2025-03-04 | 開始されました | Stifel | Buy |
| 2025-03-04 | 開始されました | TD Cowen | Buy |
Sionna Therapeutics Inc (SION) 最新ニュース
How moving averages guide Sionna Therapeutics Inc. tradingJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - Newser
Custom strategy builders for tracking Sionna Therapeutics Inc.July 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Detecting support and resistance levels for Sionna Therapeutics Inc.2025 Volume Leaders & Growth Focused Entry Reports - Newser
Sionna Therapeutics Inc. stock outlook for YEAR2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
What institutional flow reveals about Sionna Therapeutics Inc.2025 Trading Volume Trends & Reliable Price Action Trade Plans - Newser
Can Sionna Therapeutics Inc. recover in the next quarterJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.July 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Why Sionna Therapeutics Inc. is moving todayQuarterly Investment Review & Weekly Hot Stock Watchlists - Newser
How to use a screener to detect Sionna Therapeutics Inc. breakoutsRate Hike & Technical Confirmation Trade Alerts - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveTrade Entry Report & Weekly Setup with ROI Potential - Newser
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewswire
CF Drug Developer Sionna Therapeutics to Present at Major September Healthcare Conferences in NYC - Stock Titan
Sionna Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewswire Inc.
When is the best time to exit Sionna Therapeutics Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Will earnings trigger a reversal in Sionna Therapeutics Inc.2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Real time pattern detection on Sionna Therapeutics Inc. stockQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Comparing Sionna Therapeutics Inc. in custom built stock radarsWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
What machine learning models say about Sionna Therapeutics Inc.Weekly Trend Summary & Entry Point Confirmation Signals - Newser
Sionna Therapeutics Inc. stock prediction for this weekIndex Update & Weekly Breakout Stock Alerts - Newser
How to track smart money flows in Sionna Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
Trend analysis for Sionna Therapeutics Inc. this weekBull Run & Consistent Return Strategy Ideas - Newser
Will Sionna Therapeutics Inc. price bounce be sustainableWeekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Sentiment analysis tools applied to Sionna Therapeutics Inc.July 2025 Institutional & Verified Short-Term Plans - Newser
Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis - MarketScreener
Sionna Therapeutics begins phase 1 trial of CF dual combinations By Investing.com - Investing.com Canada
Sionna Therapeutics Announces First Subjects Dosed in Phase - GlobeNewswire
First-Ever NBD1 Stabilizer: Sionna's Groundbreaking CF Treatment Enters Clinical Testing for 100K Patients - Stock Titan
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionRecession Risk & Verified Entry Point Detection - Newser
Sionna Therapeutics Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.July 2025 Pullbacks & Expert Verified Movement Alerts - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Profit Summary & Precise Buy Zone Identification - Newser
What momentum shifts mean for Sionna Therapeutics Inc.July 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Full technical analysis of Sionna Therapeutics Inc. stockTreasury Yields & Weekly Market Pulse Updates - Newser
Sionna Therapeutics Inc. Shows Support at Fibonacci LevelPortfolio Gains Report & High Conviction Trade Alerts - 더경남뉴스
Can Sionna Therapeutics Inc. outperform in the next rallyQuarterly Growth Report & Technical Entry and Exit Tips - sundaytimes.kr
Sionna Therapeutics: Disrupting Vertex's CF Empire with First-in-Class NBD1 Targeting - AInvest
Sionna Therapeutics: A Differentiated Bet In The $12 Billion Cystic Fibrosis Market - Seeking Alpha
Value Recap: A | Will Sionna Therapeutics, Inc. outperform during market ralliesJuly 2025 Price Swings & Verified High Yield Trade Plans - sundaytimes.kr
Will Sionna Therapeutics Inc. benefit from government policy2025 Trade Ideas & Safe Entry Zone Tips - sundaytimes.kr
Sionna Therapeutics Inc (SION) 財務データ
Sionna Therapeutics Inc (SION) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):